Biotech Daily Dose


pharma 032317 03jul20 Today's Daily Dose brings you news about BioLife Solutions' preliminary second-quarter revenue estimate; Immunomedics' immediate catalyst; Interpace Biosciences' stock price spike; MEI Pharma discontinuing Pracinostat trial in AML patients due to lack of efficacy and disappointing outcome from Regeneron/Sanofi's study evaluating Kevzara in COVID-19 patients.

stockmarkets jan22 02jul20 What's moving these stocks in the pre-market today?

pfizer july02 Today's Daily Dose brings you news about Pfizer/BioNTech's COVID-19 vaccine trial results; Blueprint's submission of Pralsetinib NDA; reverse merger of MedAvail with MYOS; Liminal BioSciences' efforts to fight the ongoing pandemic and upsized public offering of AdaptHealth.

akero july01 Today's Daily Dose brings you news about promising histological data from Akero's phase II NASH study; positive results of Inovio's phase I clinical trial of COVID-19 vaccine candidate INO-4800; Zynerba's Fragile X Syndrome trial results; Chiasma's stock offering; update on Alterity's phase I Multiple System Atrophy trial and disappointing results of Oncocyte's DetermaDx liquid biopsy test.

akero june30 Today's Daily Dose brings you news about Akero's near-term catalyst; FDA denying approval to Heron's HTX-011 for the management of postoperative pain and Intercept's OCA for treatment of NASH; Kiniksa's RHAPSODY trial results, PDS Biotechnology's KOL meeting and regulatory update on Verrica's VP-102.

pharma 050917 24jun20 Today's Daily Dose brings you news about the expanding footprint of Apyx Medical's Helium Plasma Technology products; Inovio securing a $71 million funding from the U.S. Department of Defense for its COVID-19 vaccine delivery systems and Myovant's positive results from its second phase III trial of Relugolix combination therapy in women with pain associated with endometriosis, among others.

pharma sept27 23jun20 Today's Daily Dose brings you news about inclusion of Evelo's EDP1815 in COVID-19 trial; analyst upgrade of Five Prime; Gilead's plan to test inhaled version of experimental antiviral medicine Remdesivir; Hepion's efficacy of NASH drug candidate in mouse models of renal fibrosis; Invitae's acquisition of ArcherDX for about $1.4 billion and expanded approval of Karyopharm's Xpovio.

stockmarkets jan22 20jun20 The second quarter of 2020 is about to end in just over a week's time. The names of some of the pharma/biotech companies whose data readouts are due this quarter are listed below.

pharma 051017 19jun20 Today's Daily Dose brings you news about Alpine Immune's deal with AbbVie; FDA approval of Epizyme's TAZVERIK and Ultragenyx Pharma's Crysvita for new indications; reverse merger between privately-held Ocuphire Pharma and Rexahn Pharma and Court ruling in Biogen's Tecfidera patent suit.

pharma 051017 18jun20 Today's Daily Dose brings you news about the revocation of approval for Chembio's antibody test for COVID-19; resumption of Eloxx's cystic fibrosis trial after a brief pause due to the pandemic; encouraging results of Humanigen's Lenzilumab in COVID-19 patients; InflaRx's COVID-19 trial results and PTC Therapeutics repurposing its investigational cancer drug to treat COVID-19.

pharma sept27 17jun20 Today's Daily Dose brings you news about Amarin's settlement agreement with Apotex; Annovis Bio's progress in its Alzheimer's drug development program; IDEAYA's deal with GlaxoSmithKline; promising results of Lilly's monarchE study in breast cancer; Neurocrine Biosciences and Takeda's $2 billion-plus collaboration; and Salarius' big event for today.

walmartpharmacy jun04 16jun20 Today's Daily Dose brings you news about Momenta Pharma's positive results from myasthenia gravis trial; BeyondSpring's phase III trial results of Plinabulin in chemotherapy-induced neutropenia; Edesa's progress in COVID-19 drug trial; FDA approval of Jazz Pharma's Zepzelca and Celldex Therapeutics' stock offering.

denali june10 Today's Daily Dose brings you news about Denali halting the development of DNL747 in Alzheimer's disease and amyotrophic lateral sclerosis; the update on Immuron's research collaboration with the U.S. Naval Medical Research Center that was inked last October; the retirement plan of Inogen CEO and Intersect ENT's Sinus implant getting approval for reimbursement with a new C-Code.

solenotherapeutics june09 Today's Daily Dose brings you news about disappointing results from Soleno's Prader-Willi syndrome trial; the Court ruling in a patent infringement lawsuit filed by Opiant/Emergent against Teva; encouraging additional data from Sarepata's limb-girdle muscular dystrophy Type 2E trial; and Enochian's path forward for ENOB-HV-01, a potential cure for HIV.

coronavorus june05 The week that just passed by saw the White House selecting vaccine candidates to Operation Warp Speed; new entrants in the COVID-19 drug development space; AstraZeneca's multi deals to produce and supply its vaccine and INOVIO's trials and tribulations, among others.

Follow RTT